The US Food and Drug Administration (FDA) roadmap to reduce animal testing as a requirement for drug development has already made an impact after its first year, but the initiative faces future ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
Simplifying label-free imaging analysis for more confident real-time cell analysis Traditional cell segmentation workflows rely on time-consuming and subjective ...
Agilent Technologies Inc. (NYSE: A) today announced the launch of Agilent xCELLigence RTCA eSight AI, a new AI-powered software module that simplifies label-free imaging analysis by reducing manual ...
This module looks at the racial politics of the “roaring twenties,” a time of economic prosperity and modernism in the aftermath of World War I. Also called the Jazz Age, the era brought dramatic ...
Simplifying label-free imaging analysis for more confident real-time cell analysis Agilent Technologies Inc. (NYSE: A) today announced the launch of Agilent xCELLigence RTCA eSight AI, a new ...
Peter Gratton, Ph.D., is a New Orleans-based editor and professor with over 20 years of experience in investing, economics, and public policy. Peter began covering markets at Multex (Reuters) and has ...
A faster, smarter methodology for launching companies may make business plans obsolete. by Steve Blank Launching a new enterprise—whether it’s a tech start-up, a small business, or an initiative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results